Skip to content

How We Help
Platform & Products
About
Working At Vineti

Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS (announcement includes work with Vineti)

| About | News | Adaptimmune Starts SPEARHEAD-1 Trial…

How We Help
Platform & Products
About

LinkedIn
Twitter
Facebook

This website is not selling or providing direct patient access to cell therapy or gene therapy products or procedures. Supply chain software and other initiatives are only used for approved research or clinical trials. To find out more, including how to change your settings, see our privacy statement for details.

Site Map
Privacy Policy

© Vineti, 2023. All Rights Reserved.

We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.